* Healthequity Inc HQY.OQ HQY.O is expected to show a
rise in
quarterly revenue when it reports results on September 5.
* The Draper Utah-based company is expected to report a
16.4% increase in revenue to $239.993 million from $206.14
million a year ago, according to the mean estimate from 13
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Healthequity Inc is
for
earnings of 48 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Healthequity Inc
is $82.5, above its last closing price of $67.55.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Apr. 30 2023 0.41 0.41 0.50 Beat 23.2
Jan. 31 2023 0.35 0.35 0.37 Beat 6
Oct. 31 2022 0.35 0.35 0.38 Beat 9.7
Jul. 31 2022 0.33 0.33 0.33 Met 0
Apr. 0.25 0.26 0.27 Beat 3.8
30 2022
Jan. 31 2022 0.21 0.22 0.20 Missed -7.8
Oct. 31 2021 0.35 0.35 0.35 Met 0.8
Jul. 31 2021 0.36 0.36 0.40 Beat 10.9
This summary was machine generated September 1 at 20:05 GMT.
All figures in US dollars unless otherwise stated